deltatrials
Completed PHASE2 INTERVENTIONAL 2-arm NCT02794922

Effectiveness of Vitamin B in Reducing Temporomandibular Joint Disorder Pain

Sponsor: The University of Hong Kong

Updated 5 times since 2017 Last updated: May 1, 2018 Started: Sep 30, 2015 Primary completion: Jun 30, 2016 Completion: Jul 31, 2017
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02794922, this PHASE2 trial focuses on Temporomandibular Joint Disorder and remains completed. Sponsored by The University of Hong Kong, it has been updated 5 times since 2015, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

~Jan 2017 – ~Jun 2018 · 17 months · monthly snapshotRecruiting~Jun 2018 – ~Jan 2021 · 31 months · monthly snapshotCompleted~Jan 2021 – ~Jul 2024 · 42 months · monthly snapshotCompleted~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshotCompleted~Sep 2024 – present · 23 months · monthly snapshotCompleted

Change History

5 versions recorded
  1. Sep 2024 — Present [monthly]

    Completed PHASE2

  2. Jul 2024 — Sep 2024 [monthly]

    Completed PHASE2

  3. Jan 2021 — Jul 2024 [monthly]

    Completed PHASE2

  4. Jun 2018 — Jan 2021 [monthly]

    Completed PHASE2

    Status: RecruitingCompleted · Phase: NAPHASE2

  5. Jan 2017 — Jun 2018 [monthly]

    Recruiting NA

    First recorded

Sep 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • The University of Hong Kong
Data source: The University of Hong Kong

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations